Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 985–1008 of 1,165 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Sham-device Clear all

Conditions: Benign Essential Blepharospasm
Interventions: Magstim RapidStim2, Sham Magstim RapidStim2; Device
Lead sponsor: University of Florida; Other
Eligibility: 30 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Upper Limb Hemiparesis Following Stroke
Interventions: Task Specific Training (TST), Transcutaneous electrical spinal cord stimulation (TESS), Sham transcutaneous electrical spinal cord stimulation (Sham TESS); Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Post-cesarean Pain
Interventions: TrueRelief device, Sham TrueRelief device; Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Plantar Fasciitis
Interventions: Duolith SD1, Sham Duolith SD1; Device
Lead sponsor: Storz Medical AG; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 6
States / cities: Palo Alto, California • Hamden, Connecticut • Newtown, Connecticut + 3 more

Conditions: Healthy Adults
Interventions: LIFUP, Sham LIFUP; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 45 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Androgenetic Alopecia
Interventions: iRestore Hair Rejuvenation System, sham device; Device
Lead sponsor: Freedom Laser Therapy, Inc.; Industry
Eligibility: 25 Years to 60 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Paramus, New Jersey

Conditions: Delirium, Confusion
Interventions: Transcranial Direct Current Stimulation; Device
Lead sponsor: North Florida/South Georgia Veterans Health System; Other
Eligibility: 21 Years to 89 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Sleep Quality, Stress Reduction
Interventions: Treatment with BTL-699-2, Treatment with BTL-699-2 (sham); Device
Lead sponsor: BTL Industries Ltd.; Industry
Eligibility: 22 Years and older
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 3
States / cities: Chula Vista, California • Encinitas, California • Minooka, Illinois

Conditions: Tobacco Use Disorder
Interventions: repetitive transcranial magnetic stimulation (rTMS); Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 45 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: COVID-19
Interventions: RD-X19, Sham; Device
Lead sponsor: EmitBio Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 48
States / cities: Mesa, Arizona • Phoenix, Arizona • Anaheim, California + 42 more

Conditions: Graft-Versus-Host Disease, GVHD, Undefined
Interventions: Photobiomodulation Therapy, Placebo sham device; Device · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 4 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 9
States / cities: Bethesda, Maryland • Basking Ridge, New Jersey • Middletown, New Jersey + 6 more

Conditions: Fatigue
Interventions: transcranial direct current stimulation, sham tDCS; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 40 Years
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe, Withdrawal Symptoms, Craving, Negative Affectivity
Interventions: CBOT + TAU, Sham + TAU; Drug
Lead sponsor: Evon Medics LLC; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Rockville, Maryland

Conditions: Overactive Bladder (OAB)
Interventions: Tensi+; Device
Lead sponsor: Stimuli Technology; Industry
Eligibility: 22 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Beverly Hills, California • New York, New York

Conditions: Long COVID, Long COVID-19, Long COVID19
Interventions: BrainHQ/Active Comparator Activity, BrainHQ, PASC CoRE, tDCS-active, tDCS-sham; Other · Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 328 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 24
States / cities: Phoenix, Arizona • Tucson, Arizona • Los Angeles, California + 20 more

Conditions: Stroke, Chronic Stroke, Hemorrhage Brain, Ischemic Stroke
Interventions: Transcranial direct current stimulation (tDCS) with OT, Sham tDCS with OT; Device
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Peripheral Artery Disease, Peripheral Vascular Disease, Aging, Walking, Difficulty
Interventions: Far red light therapy, Sham light therapy; Device
Lead sponsor: Northwestern University; Other
Eligibility: 50 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Birmingham, Alabama • Chicago, Illinois

Conditions: Facet Syndrome of Lumbar Spine
Interventions: Non-Invasive Thermal Ablation of the Medial Branch Nerves (Neurolyser XR), Sham procedure; Device · Other
Lead sponsor: FUSMobile Inc.; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 10
States / cities: Stamford, Connecticut • Jacksonville, Florida • Miami, Florida + 6 more

Conditions: Chemotherapy-induced Peripheral Neuropathy
Interventions: transcranial direct current stimulation Soterix REMOTE 1x1 miniCT; Device
Lead sponsor: Morgan State University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Spinal Cord Injury (SCI), Neurogenic Bladder (NB)
Interventions: iTNS, Sham iTNS; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 75 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Post-Acute COVID-19 Syndrome, Cognitive Dysfunction
Interventions: Pascal device, Sham Device; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Laryngopharyngeal Reflux
Interventions: External Upper Esophageal Sphincter (UES) Compression Device, Sham Device; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 99 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Chronic Low Back Pain (CLBP), Intervertebral Disc Displacement
Interventions: Sustained Acoustic Medicine (SAM), Sham Device; Device
Lead sponsor: ZetrOZ, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 3
States / cities: Dryden, New York • Chapel Hill, North Carolina • Ogden, Utah

Conditions: Traumatic Brain Injury
Interventions: Nurosym taVNS, Nurosym (sham); Device
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: San Antonio, Texas

Search by objective public record fields.

rTMS and Botulinum Toxin in Benign Essential Blepharospasm

Transcutaneous Electrical Stimulation for Stroke Patients

TrueRelief Efficacy for Post-cesarean Pain (ELECTRON)

Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome

Low Intensity Focused Ultrasound Pulses (LIFUP) to Modulate Pain

24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness

Transcranial Direct Current Stimulation for the Treatment of Delirium

EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress

Transcranial Magnetic Stimulation and Tobacco Use Disorder

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

Impact of Transcranial Direct Current Stimulation on Fatigability and Fatigue Induced by a Selective Attention Task

Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder

Tensi+ for Treating Overactive Bladder

RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms

Personalized Transcranial Direct Current Stimulation in Stroke Recovery

Far Red Light to Improve Functioning in PAD

Double Arm Pivotal Study to Evaluate the Neurolyser XR for the Treatment of Chronic Low Back Pain

Neural and Immune Correlates of CIPN and Possible Analgesic Effect of Non-invasive Motor Cortex Stimulation

Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury

Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction

Reflux Band in Laryngopharyngeal Reflux

Sustained Acoustic Medicine for Chronic Low Back Pain Secondary to Herniated Nucleus Pulposus or Other Conditions

Modulating Inflammation in Neuro-Trauma